Cargando…
Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease?
The inflammatory response to and the subsequent development of Adult Respiratory Distress Syndrome (ARDS) is considered to underpin COVID-19 pathogenesis. With a developing world catastrophe, we need to examine our known therapeutic stocks, to assess suitability for prevention and/or treatment of th...
Autor principal: | Verrall, Geoffrey Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493671/ https://www.ncbi.nlm.nih.gov/pubmed/33013911 http://dx.doi.org/10.3389/fimmu.2020.02167 |
Ejemplares similares
-
Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review
por: Barrett, Christopher D., et al.
Publicado: (2020) -
Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale
por: Mulia, Eka Prasetya Budi, et al.
Publicado: (2021) -
Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?
por: Navarese, Eliano Pio, et al.
Publicado: (2013) -
Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome
por: Tovar, Isabel, et al.
Publicado: (2020) -
Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019
por: Villar, Jesús, et al.
Publicado: (2020)